Birdwatch Note
2024-04-30 23:26:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
AstraZeneca COVID-19 vaccine adverse reactions were never hidden or suppressed. AstraZeneca highlighted blood clots as a rare COVID vaccine side effect in 2021: https://www.astrazeneca.com/media-centre/press-releases/2021/vaxzevria-and-mrna-covid-19-vaccines-showed-similar-and-favourable-safety-profiles-in-a-population-based-cohort-study-of-over-a-million-people.html#! This was widely covered by mainstream media at the time: https://ncbi.nlm.nih.gov/pmc/articles/PMC10478733 https://ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets https://cnbc.com/2021/08/12/blood-clots-linked-to-astrazeneca-shot-have-22percent-mortality-rate-study.html
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785427686506242121
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785450570675089635
- noteId - 1785450570675089635
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1714519562774
- tweetId - 1785427686506242121
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- AstraZeneca COVID-19 vaccine adverse reactions were never hidden or suppressed. AstraZeneca highlighted blood clots as a rare COVID vaccine side effect in 2021: https://www.astrazeneca.com/media-centre/press-releases/2021/vaxzevria-and-mrna-covid-19-vaccines-showed-similar-and-favourable-safety-profiles-in-a-population-based-cohort-study-of-over-a-million-people.html#! This was widely covered by mainstream media at the time: https://ncbi.nlm.nih.gov/pmc/articles/PMC10478733 https://ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets https://cnbc.com/2021/08/12/blood-clots-linked-to-astrazeneca-shot-have-22percent-mortality-rate-study.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-30 23:26:02 UTC (1714519562774) |
2024-05-01 08:09:49 UTC (1714550989003) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 08:09:49 UTC (1714550989003) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-30 19:20:52 -0500 | Rating Details | |
2024-04-30 19:20:17 -0500 | Rating Details | |
2024-04-30 19:07:06 -0500 | Rating Details | |
2024-04-30 19:02:38 -0500 | Rating Details | |
2024-04-30 19:01:39 -0500 | Rating Details | |
2024-04-30 19:00:58 -0500 | Rating Details | |
2024-04-30 18:57:00 -0500 | Rating Details | |
2024-04-30 18:55:37 -0500 | Rating Details | |
2024-04-30 18:54:38 -0500 | Rating Details | |
2024-04-30 18:51:36 -0500 | Rating Details | |
2024-04-30 18:50:30 -0500 | Rating Details | |
2024-04-30 18:49:27 -0500 | Rating Details | |
2024-04-30 18:48:26 -0500 | Rating Details | |
2024-04-30 18:46:57 -0500 | Rating Details | |
2024-04-30 18:46:46 -0500 | Rating Details | |
2024-04-30 18:28:57 -0500 | Rating Details | |
2024-05-01 12:47:05 -0500 | Rating Details | |
2024-05-01 11:32:07 -0500 | Rating Details | |
2024-05-01 11:04:54 -0500 | Rating Details | |
2024-05-01 09:13:05 -0500 | Rating Details | |
2024-05-01 08:12:40 -0500 | Rating Details | |
2024-05-01 07:17:59 -0500 | Rating Details | |
2024-05-01 06:03:51 -0500 | Rating Details | |
2024-05-01 03:30:54 -0500 | Rating Details | |
2024-05-01 02:20:38 -0500 | Rating Details | |
2024-04-30 23:40:06 -0500 | Rating Details | |
2024-04-30 23:23:47 -0500 | Rating Details | |
2024-04-30 22:00:57 -0500 | Rating Details | |
2024-04-30 21:43:06 -0500 | Rating Details | |
2024-04-30 21:32:52 -0500 | Rating Details | |
2024-04-30 21:20:46 -0500 | Rating Details | |
2024-04-30 20:13:37 -0500 | Rating Details | |
2024-04-30 20:12:26 -0500 | Rating Details | |
2024-04-30 20:05:50 -0500 | Rating Details | |
2024-04-30 20:05:49 -0500 | Rating Details | |
2024-04-30 20:04:59 -0500 | Rating Details | |
2024-04-30 20:03:29 -0500 | Rating Details | |
2024-04-30 19:44:22 -0500 | Rating Details | |
2024-04-30 19:34:28 -0500 | Rating Details | |
2024-05-01 20:03:33 -0500 | Rating Details | |
2024-05-01 15:31:45 -0500 | Rating Details | |
2024-05-01 14:19:28 -0500 | Rating Details | |
2024-05-01 13:14:40 -0500 | Rating Details | |
2024-05-01 11:38:12 -0500 | Rating Details | |
2024-05-01 09:34:01 -0500 | Rating Details | |
2024-05-01 07:25:07 -0500 | Rating Details | |
2024-05-01 06:31:59 -0500 | Rating Details | |
2024-05-01 04:50:36 -0500 | Rating Details | |
2024-05-01 03:20:34 -0500 | Rating Details | |
2024-05-01 03:14:51 -0500 | Rating Details | |
2024-05-01 02:04:09 -0500 | Rating Details | |
2024-04-30 23:47:16 -0500 | Rating Details | |
2024-04-30 21:18:37 -0500 | Rating Details | |
2024-04-30 21:11:27 -0500 | Rating Details | |
2024-04-30 20:17:45 -0500 | Rating Details | |
2024-04-30 20:03:08 -0500 | Rating Details | |
2024-04-30 19:42:27 -0500 | Rating Details | |
2024-04-30 19:19:25 -0500 | Rating Details | |
2024-04-30 19:18:06 -0500 | Rating Details | |
2024-04-30 19:14:08 -0500 | Rating Details | |
2024-04-30 19:11:30 -0500 | Rating Details | |
2024-04-30 19:10:58 -0500 | Rating Details | |
2024-04-30 19:05:09 -0500 | Rating Details | |
2024-04-30 19:01:34 -0500 | Rating Details | |
2024-04-30 18:49:35 -0500 | Rating Details | |
2024-04-30 18:48:56 -0500 | Rating Details | |
2024-04-30 18:48:22 -0500 | Rating Details | |
2024-04-30 18:47:08 -0500 | Rating Details | |
2024-04-30 18:44:05 -0500 | Rating Details | |
2024-04-30 18:36:40 -0500 | Rating Details | |
2024-04-30 18:35:56 -0500 | Rating Details | |
2024-05-02 06:07:01 -0500 | Rating Details | |
2024-05-01 17:16:29 -0500 | Rating Details | |
2024-05-01 14:04:45 -0500 | Rating Details | |
2024-05-01 10:16:26 -0500 | Rating Details | |
2024-05-01 08:32:47 -0500 | Rating Details | |
2024-05-01 08:17:21 -0500 | Rating Details | |
2024-05-01 07:54:21 -0500 | Rating Details | |
2024-05-01 07:18:51 -0500 | Rating Details | |
2024-05-01 05:34:40 -0500 | Rating Details | |
2024-05-01 05:19:32 -0500 | Rating Details | |
2024-05-01 03:15:51 -0500 | Rating Details | |
2024-05-01 00:32:51 -0500 | Rating Details | |
2024-05-01 00:26:53 -0500 | Rating Details | |
2024-04-30 23:08:21 -0500 | Rating Details | |
2024-04-30 22:19:58 -0500 | Rating Details | |
2024-04-30 21:52:50 -0500 | Rating Details | |
2024-04-30 21:43:54 -0500 | Rating Details | |
2024-04-30 21:39:53 -0500 | Rating Details | |
2024-04-30 21:34:17 -0500 | Rating Details | |
2024-04-30 21:06:01 -0500 | Rating Details | |
2024-04-30 20:18:43 -0500 | Rating Details | |
2024-04-30 20:16:22 -0500 | Rating Details | |
2024-04-30 20:15:11 -0500 | Rating Details | |
2024-04-30 20:13:13 -0500 | Rating Details | |
2024-04-30 20:05:42 -0500 | Rating Details | |
2024-04-30 19:56:51 -0500 | Rating Details | |
2024-04-30 19:53:59 -0500 | Rating Details | |
2024-04-30 19:42:01 -0500 | Rating Details | |
2024-04-30 19:41:40 -0500 | Rating Details | |
2024-04-30 19:35:00 -0500 | Rating Details | |
2024-04-30 19:29:25 -0500 | Rating Details | |
2024-04-30 19:26:45 -0500 | Rating Details | |
2024-04-30 19:22:59 -0500 | Rating Details | |
2024-04-30 19:03:48 -0500 | Rating Details | |
2024-04-30 19:02:57 -0500 | Rating Details | |
2024-04-30 19:02:26 -0500 | Rating Details | |
2024-04-30 19:01:30 -0500 | Rating Details | |
2024-04-30 18:56:06 -0500 | Rating Details | |
2024-04-30 18:54:10 -0500 | Rating Details | |
2024-04-30 18:53:33 -0500 | Rating Details | |
2024-04-30 18:52:31 -0500 | Rating Details | |
2024-04-30 18:52:11 -0500 | Rating Details | |
2024-04-30 18:51:07 -0500 | Rating Details | |
2024-04-30 18:50:02 -0500 | Rating Details | |
2024-04-30 18:47:39 -0500 | Rating Details | |
2024-04-30 18:46:33 -0500 | Rating Details | |
2024-04-30 18:45:26 -0500 | Rating Details | |
2024-04-30 18:43:36 -0500 | Rating Details | |
2024-04-30 18:37:52 -0500 | Rating Details | |
2024-04-30 18:35:06 -0500 | Rating Details | |
2024-05-02 01:55:50 -0500 | Rating Details | |
2024-05-01 16:59:13 -0500 | Rating Details | |
2024-05-01 15:23:50 -0500 | Rating Details | |
2024-05-01 12:56:04 -0500 | Rating Details | |
2024-05-01 08:43:14 -0500 | Rating Details | |
2024-05-01 07:12:15 -0500 | Rating Details | |
2024-05-01 04:44:10 -0500 | Rating Details | |
2024-05-01 01:20:22 -0500 | Rating Details | |
2024-04-30 22:50:13 -0500 | Rating Details | |
2024-04-30 22:01:04 -0500 | Rating Details | |
2024-04-30 21:03:15 -0500 | Rating Details | |
2024-04-30 20:08:01 -0500 | Rating Details | |
2024-04-30 20:02:07 -0500 | Rating Details | |
2024-04-30 20:00:47 -0500 | Rating Details | |
2024-04-30 19:46:31 -0500 | Rating Details | |
2024-04-30 19:31:51 -0500 | Rating Details | |
2024-04-30 19:27:47 -0500 | Rating Details | |
2024-04-30 19:19:02 -0500 | Rating Details | |
2024-04-30 19:17:03 -0500 | Rating Details | |
2024-04-30 19:05:05 -0500 | Rating Details | |
2024-04-30 19:04:32 -0500 | Rating Details | |
2024-04-30 19:00:09 -0500 | Rating Details | |
2024-04-30 18:58:35 -0500 | Rating Details | |
2024-04-30 18:55:28 -0500 | Rating Details | |
2024-04-30 18:49:45 -0500 | Rating Details | |
2024-04-30 18:49:44 -0500 | Rating Details | |
2024-04-30 18:48:49 -0500 | Rating Details | |
2024-04-30 18:46:45 -0500 | Rating Details | |
2024-05-01 10:12:24 -0500 | Rating Details | |
2024-05-01 09:29:49 -0500 | Rating Details | |
2024-04-30 21:31:40 -0500 | Rating Details | |
2024-04-30 18:50:29 -0500 | Rating Details | |
2024-04-30 18:44:34 -0500 | Rating Details | |
2024-05-01 03:29:24 -0500 | Rating Details | |
2024-05-01 03:20:35 -0500 | Rating Details | |
2024-04-30 21:41:47 -0500 | Rating Details | |
2024-04-30 20:50:24 -0500 | Rating Details | |
2024-04-30 20:08:58 -0500 | Rating Details | |
2024-06-03 00:09:39 -0500 | Rating Details |